13F HOLDINGS REPORT (Amended)
Eversept Partners, LP
Quarter ended Q4 2023 · Filed November 8, 2023 · Accession 0001697013-23-000013
Total Value
$322.4M
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE PLC | GLAXF | 983,085 | $42.3M | 13.13% |
| 2 | ENSIGN GROUP INC | ENSG | 586,674 | $27.8M | 8.64% |
| 3 | DANAHER CORPORATION | 235851102 | 178,704 | $25.8M | 8.02% |
| 4 | ZOGENIX INC | 98978L204 | 643,818 | $25.8M | 8.00% |
| 5 | ASCENDIS PHARMA A S | ASND | 236,392 | $22.8M | 7.06% |
| 6 | AMARIN CORP PLC | AMRN | 1,329,695 | $20.2M | 6.25% |
| 7 | SANOFI | SNYNF | 240,000 | $11.1M | 3.45% |
| 8 | RADIUS HEALTH INC | 750469207 | 344,698 | $8.9M | 2.75% |
| 9 | ENVISTA HLDGS CORP | NVST | 318,000 | $8.9M | 2.75% |
| 10 | VERTEX PHARMACEUTICALS INC | VRTX | 50,909 | $8.6M | 2.68% |
| 11 | ILLUMINA INC | ILMN | 26,750 | $8.1M | 2.52% |
| 12 | ALNYLAM PHARMACEUTICALS INC | ALNY | 92,040 | $7.4M | 2.30% |
| 13 | AUDENTES THERAPEUTICS INC | 05070R104 | 253,726 | $7.1M | 2.21% |
| 14 | DEXCOM INC | DXCM | 44,550 | $6.6M | 2.06% |
| 15 | R1 RCM INC | 749397105 | 725,972 | $6.5M | 2.01% |
| 16 | ABIOMED INC | 003654100 | 29,950 | $5.3M | 1.65% |
| 17 | OMEGA HEALTHCARE INVS INC | 681936100 | 106,500 | $4.5M | 1.38% |
| 18 | TG THERAPEUTICS INC | TGTX | 773,501 | $4.3M | 1.35% |
| 19 | OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | 256,000 | $4.3M | 1.32% |
| 20 | TELIGENT INC NEW | 87960W104 | 4,424,222 | $4.2M | 1.30% |
| 21 | ARGENX SE | ARGX | 36,004 | $4.1M | 1.27% |
| 22 | LTC PPTYS INC | 502175102 | 69,327 | $3.6M | 1.10% |
| 23 | SABRA HEALTH CARE REIT INC | SBRA | 154,100 | $3.5M | 1.10% |
| 24 | MODEL N INC | 607525102 | 120,695 | $3.4M | 1.04% |
| 25 | CARETRUST REIT INC | CTRE | 137,464 | $3.3M | 1.01% |
| 26 | BIODELIVERY SCIENCES INTL IN | 09060J106 | 708,020 | $3.0M | 0.92% |
| 27 | ARQULE INC | ARQ | 412,388 | $3.0M | 0.92% |
| 28 | HESKA CORP | 42805E306 | 40,824 | $2.9M | 0.90% |
| 29 | EHEALTH INC | EHTH | 42,653 | $2.8M | 0.88% |
| 30 | AMARIN CORP PLC | AMRN | 161,100 | $2.4M | 0.76% |
| 31 | COMMUNITY HEALTH SYS INC NEW | 203668108 | 607,383 | $2.2M | 0.68% |
| 32 | FATE THERAPEUTICS INC | FATE | 140,656 | $2.2M | 0.68% |
| 33 | CYTOKINETICS INC | CYTK | 181,700 | $2.1M | 0.64% |
| 34 | TRICIDA INC | 89610F101 | 65,568 | $2.0M | 0.63% |
| 35 | MACROGENICS INC | MGNX | 154,824 | $2.0M | 0.61% |
| 36 | XENON PHARMACEUTICALS INC | XENE | 215,609 | $1.9M | 0.60% |
| 37 | APELLIS PHARMACEUTICALS INC | APLS | 79,509 | $1.9M | 0.59% |
| 38 | BIOCRYST PHARMACEUTICALS | BCRX | 654,460 | $1.9M | 0.58% |
| 39 | COLLEGIUM PHARMACEUTICAL INC | COLL | 160,295 | $1.8M | 0.57% |
| 40 | SCPHARMACEUTICALS INC | 810648105 | 221,636 | $1.3M | 0.40% |
| 41 | AGILE THERAPEUTICS INC | AGBK | 909,485 | $1.1M | 0.33% |
| 42 | INVACARE CORP | 461203101 | 129,361 | $970,208 | 0.30% |
| 43 | AFFIMED N V | N01045108 | 322,171 | $947,183 | 0.29% |
| 44 | OTONOMY INC | 68906L105 | 376,342 | $899,457 | 0.28% |
| 45 | CODEXIS INC | CDXS | 63,000 | $864,045 | 0.27% |
| 46 | SAVARA INC | SVRA | 316,679 | $839,199 | 0.26% |
| 47 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 22,000 | $746,680 | 0.23% |
| 48 | OPTINOSE INC | 68404V100 | 105,106 | $735,742 | 0.23% |
| 49 | EIGER BIOPHARMACEUTICALS INC | 28249U105 | 69,708 | $714,507 | 0.22% |
| 50 | DICERNA PHARMACEUTICALS INC | 253031108 | 41,074 | $589,823 | 0.18% |
| 51 | NEWLINK GENETICS CORP | 651511107 | 272,983 | $434,043 | 0.13% |
| 52 | PFENEX INC | 717071104 | 47,968 | $404,850 | 0.13% |
| 53 | CEL SCI CORP | CVM | 42,800 | $382,632 | 0.12% |
| 54 | ALBIREO PHARMA INC | 01345P106 | 18,029 | $360,580 | 0.11% |
| 55 | AIMMUNE THERAPEUTICS INC | 00900T107 | 10,000 | $209,400 | 0.06% |
| 56 | AIMMUNE THERAPEUTICS INC | 00900T107 | 9,100 | $190,554 | 0.06% |
| 57 | AKORN INC | 009728106 | 40,242 | $152,920 | 0.05% |